<SEC-DOCUMENT>0000096943-17-000110.txt : 20171002
<SEC-HEADER>0000096943-17-000110.hdr.sgml : 20171002
<ACCEPTANCE-DATETIME>20171002172632
ACCESSION NUMBER:		0000096943-17-000110
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20171002
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171002
DATE AS OF CHANGE:		20171002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TELEFLEX INC
		CENTRAL INDEX KEY:			0000096943
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				231147939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05353
		FILM NUMBER:		171115454

	BUSINESS ADDRESS:	
		STREET 1:		550 E SWEDESFORD RD
		STREET 2:		SUITE 400
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
		BUSINESS PHONE:		610-225-6800

	MAIL ADDRESS:	
		STREET 1:		550 E SWEDESFORD RD
		STREET 2:		SUITE 400
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a10-2x20178xkreneotractclo.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s2d14757a8649418db263d13a98747e9a"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:4px;text-align:center;-sec-extract:summary;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, DC 20549</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:5px;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:79.8828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:44%;"></td><td style="width:56%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date of Report (Date of Earliest Event Reported)  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">October 2, 2017</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">TELEFLEX INCORPORATED</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Exact name of Registrant as Specified in Its Charter)</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:30%;"></td><td style="width:36%;"></td><td style="width:34%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">1-5353 </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">23-1147939</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:2px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(State or Other Jurisdiction</font></div><div style="padding-top:2px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">of Incorporation or Organization)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Commission File Number) </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:2px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(IRS Employer</font></div><div style="padding-top:2px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.1640625%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:34%;"></td><td style="width:15%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">550 East Swedesford Road, Suite 400, Wayne, Pennsylvania</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">19,087</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Zip Code)</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:53px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Registrant&#8217;s Telephone Number, Including Area Code</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(610) 225-6800</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.359375%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Not applicable</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Former Name or Former Address, If Changed Since Last Report)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Item 2.01. </font><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Completion of Acquisition or Disposition of Assets. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On October 2, 2017, Teleflex Incorporated (the &#8220;Company&#8221;) completed its previously announced acquisition of NeoTract, Inc. (&#8220;NeoTract&#8221;), pursuant to that certain Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), dated as of September 4, 2017, by and among the Company, Teleflex Urology Limited, a private limited company incorporate under the laws of Ireland (&#8220;Teleflex Urology&#8221;), NeoTract and Naples Merger Sub Inc., a wholly-owned subsidiary of the Teleflex Urology (&#8220;Merger Sub&#8221;). Pursuant to the Merger Agreement, Merger Sub merged with and into NeoTract (the &#8220;Merger&#8221;), with NeoTract surviving the Merger as a wholly-owned subsidiary of Teleflex Urology.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">At the closing, Teleflex Urology paid a purchase price of $725 million in cash, subject to customary purchase price adjustments, and the Merger Agreement provides for additional milestone payments by Teleflex Urology of up to $375 million in the aggregate, which milestone payments are each subject to certain net sales requirements with respect to sales of certain products as further described in the Merger Agreement. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">The description of the Merger and the Merger Agreement contained in this Item 2.01 does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement, which was filed as Exhibit 2.1 to the Form 8-K filed by the Company with the Securities and Exchange Commission on September 5, 2017, and is incorporated by reference herein.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Item 8.01. </font><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Other Events.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">On October 2, 2017, the Company issued a press release announcing the completion of its acquisition of NeoTract, a copy of which is filed as Exhibit 99.1 and is incorporated herein by reference. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Item 9.01. </font><font style="font-family:inherit;font-size:11pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">(d)&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Exhibits</font><font style="font-family:inherit;font-size:11pt;">.  The following exhibits are filed as part of this report:</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">99.1&#160;&#160;&#160;&#160;Press Release, dated October 2, 2017. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:144px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:144px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.359375%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Date: October 2, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">TELEFLEX INCORPORATED</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:  </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ James J. Leyden</font><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="padding-left:28px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name: James J. Leyden</font></div><div style="padding-left:78px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Title:   Vice President, General Counsel and Secretary</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:40px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.0703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:14%;"></td><td style="width:2%;"></td><td style="width:84%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Exhibit No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;text-decoration:underline;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit991to10-2x20178xkre.htm"><font style="font-family:inherit;font-size:11pt;">99.1</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:11pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit991to10-2x20178xkre.htm"><font style="font-family:inherit;font-size:11pt;">Press Release, dated October 2, 2017</font></a></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991to10-2x20178xkre.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2017 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sac4fcec61c514491b80479d7ce36fa71"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;padding-bottom:9px;text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Exhibit 99.1</font></div><div style="line-height:120%;"><img src="tfxcorpclr73.jpg" alt="tfxcorpclr73.jpg" style="height:44px;width:288px;"></div><div style="line-height:174%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:66.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:17%;"></td><td style="width:83%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Contact:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font><font style="font-family:Arial;font-size:10pt;">Jake Elguicze</font></div><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;Treasurer and Vice President of Investor Relations</font></div><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;610-948-2836</font></div></td></tr></table></div></div><div style="line-height:232%;padding-top:20px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:20px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">FOR IMMEDIATE RELEASE</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:20px;text-align:right;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">October 2, 2017</font></div></td></tr></table></div></div><div style="line-height:232%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">TELEFLEX INCORPORATED COMPLETES ACQUISITION OF NEOTRACT</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Wayne, PA -- </font><font style="font-family:Arial;font-size:10pt;">Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies designed to improve the health and quality of people&#8217;s lives, announced today the completion of its previously announced acquisition of NeoTract, Inc.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On September 5, 2017, the two companies announced a definitive agreement for Teleflex to acquire NeoTract in a transaction valued at up to $1.1 billion. Under the terms of the agreement, Teleflex acquired NeoTract for an upfront cash payment of $725 million at closing, and has agreed to pay up to an additional $375 million upon the achievement of certain commercial milestones related to sales through the end of 2020.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Founded in 2004, </font><font style="font-family:Arial;font-size:10pt;color:#2e2e2e;">NeoTract is a privately-held medical device company that has developed and commercialized the  FDA-cleared UroLift&#174; System, a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia, or BPH. Performed primarily through a transurethral outpatient procedure, the UroLift&#174; System delivers permanent implants that hold open the urethra, reducing the prostate obstruction without cutting, heating, or removing prostate tissue.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Teleflex will provide additional details on the transaction, including an update to its fiscal year 2017 financial outlook as a result of this transaction, on its third quarter 2017 investor conference call. </font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ABOUT TELEFLEX INCORPORATED</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Teleflex is a global provider of medical technologies designed to improve the health and quality of people&#8217;s lives. We apply purpose driven innovation - a relentless pursuit of identifying unmet clinical needs - to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Teleflex is the home of Arrow</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Deknatel</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Hudson RCI</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, LMA</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Pilling</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Rusch</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">&#32;and Weck</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">&#32;- trusted brands united by a common sense of purpose.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ABOUT NEOTRACT, INC.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#2e2e2e;">NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. The company&#8217;s initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function. Learn more at </font><font style="font-family:Arial;font-size:10pt;color:#0000ff;text-decoration:underline;">www.NeoTract.com</font><font style="font-family:Arial;font-size:10pt;color:#2e2e2e;">.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tfxcorpclr73.jpg
<TEXT>
begin 644 tfxcorpclr73.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_X0H=17AI9@  34T *@    @ !P$2  ,
M   !  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q
M  (    4    <@$R  (    4    AH=I  0    !    G    ,@   !(
M 0   $@    !061O8F4@4&AO=&]S:&]P(#<N,  R,# T.C R.C R(#$V.C$R
M.C0V      .@ 0 #     ?__  "@ @ $     0   -B@ P $     0   "$
M        !@$#  ,    !  8   $:  4    !   !%@$;  4    !   !'@$H
M  ,    !  (   (!  0    !   !)@("  0    !   ([P        !(
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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M $@      MX"0/_N_^X#!@)2 V<%* /\  (   !( $@      M@"*  !
M9     $  P,#     7__  $  0               &@( !D!D       (
M                                .$))30/M       0 $@    !  $
M2     $  3A"24T$)@      #@             _@   .$))300-       $
M    'CA"24T$&0      !    !XX0DE- _,       D           $ .$))
M300*       !   X0DE-)Q        H  0         !.$))30/U      !(
M "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H
M   &       ! #4    ! "T    &       !.$))30/X      !P  #_____
M________________________ ^@     ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@  #A"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      -9    !@              (0
M -@    2 '0 9@!X "T 8P!O '( <  M #$ -0 P "T 8P!O &P ;P!R
M 0                         !              #8    (0
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    (0    !29VAT
M;&]N9P   -@    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))3004       $
M CA"24T$#      )"P    $   "     %    8   !X    ([P 8  '_V/_@
M !!*1DE&  $" 0!( $@  /_M  Q!9&]B95]#30 !_^X #D%D;V)E &2
M ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.
M#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M_\  $0@ % "  P$B  (1 0,1 ?_=  0 "/_$ 3\   $% 0$! 0$!
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MU.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\
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M+]S_ (7U/2_1+PY)"7^YX^?Z7_<*'\Z=MNG_ '3_ /_9 #A"24T$(0
M50    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !,
M00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  (  W "X ,     $ .$))
M30^@      C:;6]P=     ,    !          <      0
M    @          !    6                     $     _____P     $
M_____P    #_____     /____\     _____P          _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M_P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M_P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M_P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M_P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M_P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\   #_
M    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P   /\
M  #_    _P   /\   #_    _P   /\   #_    _P   /\   #_    _P
M /\   #_    _P   /\   #_    _P                  !%@    0
M 0      #E1A<F=E=%-E='1I;F=S    %     5L;W-S>6QO;F<
M $-L<E1/8FIC     0      "D-O;&]R5&%B;&4    "    !VES17AA8W1B
M;V]L      !#;')S5FQ,<P         *875T;U)E9'5C96)O;VP     "WIO
M;F5D1&ET:&5R3V)J8P    $       E:;VYE9$EN9F\    $    #65M<&AA
M<VEZ951E>'1B;V]L     !!E;7!H87-I>F5696-T;W)S8F]O;      %9FQO
M;W)L;VYG          EC:&%N;F5L241L;VYG_____P    !-='1#3V)J8P
M  $       I.871I=F51=6%D     P    !";" @;&]N9P   /\     1W)N
M(&QO;F<   #_     %)D("!L;VYG    _P    EN=6U#;VQO<G-L;VYG
M@     IZ;VYE9$QO<W-Y3V)J8P    $       E:;VYE9$EN9F\    $
M#65M<&AA<VEZ951E>'1B;V]L     !!E;7!H87-I>F5696-T;W)S8F]O;
M   %9FQO;W)L;VYG          EC:&%N;F5L241L;VYG_____P    II;G1E
M<FQA8V5D8F]O;      *9FEL949O<FUA=&5N=6T    *1FEL949O<FUA=
M  -'248     5')N<V)O;VP!    #V1I=&AE<D%L9V]R:71H;65N=6T    /
M1&ET:&5R06QG;W)I=&AM     $1F<VX    -9&ET:&5R4&5R8V5N=&QO;F<
M  !8    &'1R86YS<&%R96YC>41I=&AE<D%M;W5N=&QO;F<   !D    &W1R
M86YS<&%R96YC>41I=&AE<D%L9V]R:71H;65N=6T    /1&ET:&5R06QG;W)I
M=&AM     $YO;F4    4>F]N961(:7-T;V=R86U796EG:'1/8FIC     0
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M     0      !&YU;&P    !    !U9E<G-I;VYL;VYG       X0DE-! 8
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M86-K970@96YD/2=W)S\^_^(%8$E#0U]04D]&24Q%  $!   %4&%P<&P"(
M;6YT<E)'0B!865H@!]( !0 -  P     86-S<$%04$P     87!P;
M              $  /;6  $     TRUA<'!L
M                                       -<EA96@   2     49UA9
M6@   30    48EA96@   4@    4=W1P=    5P    48VAA9    7     L
M<E120P   9P    .9U120P   9P    .8E120P   9P    .9&5S8P   :P
M   _8W!R=    >P    M=F-G=    AP    P;F1I;@   DP    X9'-C;0
M H0   +*6%E:(        '1+   ^'0   \M865H@        6G,  *RF   7
M)EA96B         H&   %5<  +@S6%E:(        /-2  $    !%L]S9C,R
M       !#$(   7>___S)@  !Y(  /V1___[HO___:,   /<  # ;&-U<G8
M         0'-  !D97-C         !1'96YE<FEC(%)'0B!0<F]F:6QE
M           41V5N97)I8R!21T(@4')O9FEL90  =&5X=     !#;W!Y<FEG
M:'0@07!P;&4@0V]M<'5T97(L($EN8RXL(#(P,#(     =F-G=          !
M  "X4@       0    "X4@       0    "X4@       0  ;F1I;@
M   X  "A2   5PH  $N%  ":X0  )ZX  !.V  !0#0  5#D  H    *    "
M@ !M;'5C         !     ,96Y54P   "8   #09&%$2P   "X   (<9&5$
M10   "P   )*97-%4P   "8   %&9FE&20   "@   )V9G(      "@   '.
M:71)5    "@   #V;FQ.3    "@   $>;F].3P   "8   %L<'1"4@   "8
M  'V<W9310   "8   %L=')44@   "(   &L:F%*4    !H   &2:V]+4@
M !8   *>>FA#3@   !8   *T>FA45P   "8   #0 $< 90!N &4 <@!I &,
M( !2 $< 0@ @ %  <@!O &8 :0!L &4 4 !R &\ 9@!I &P ;P @ %( 1P!"
M "  1P!E &X 90!R &D 8P!O $$ ; !G &4 ;0!E &4 ;@ @ %( 1P!" "T
M< !R &\ 9@!I &4 ; !0 &4 <@!F &D ;  @ %( 1P!" "  9P!E &X Z0!R
M &D 8P!O $< 90!N &4 <@!I ', :P @ %( 1P!" "T < !R &\ 9@!I &Q.
M ((L "  4@!' $( (##7,.TPU3"A,*0PZP!' &4 ;@!E &P ( !2 $< 0@ @
M $( 90!L &< :0!S &D 4 !R &\ 9@!I &P ( !G .D ;@#I '( :0!Q '4
M90 @ %( 5@!" %  90!R &8 :0!L "  4@!' $( ( !' &4 ;@#I '( :0!C
M &\ 1P!E &X 90!R &4 ;  @ %( 1P!" "T 8@!E ', :P!R &D =@!E &P
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M# P,# P,# P,# P,#/_  !$( "$ V ,!$0 "$0$#$0'_W0 $ !O_Q &B
M!P$! 0$!           $!0,"!@$ !P@)"@L!  (" P$! 0$!          $
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MYS_Y^&_\Y W&NI^4WYF?F+YM/EU87UVXC\PBRM[8W//T4:2YGACY/Z;$*N]
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M_P ^W/\ UJ3R+_QDG_ZAY<TO;W^*R=CV=];RGS]_Y-7SS_X&.I?]U"3+L/\
M=1_JC[F4OK^+^MKRU_RCF@?]LVU_Y,KGG$_J/O=Y'D^!/^?G_P#ZS7#_ .!9
MI?\ Q"?-SV!_C/P/Z'%UGT/YX\[9U+^CC_GVI_ZRMY;_ .VUK'_44V<-V[_C
)1]P=QI/[M__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
